Avanos Medical, Inc. (NYSE: AVNS) is a leading medical technology company dedicated to delivering innovative solutions that improve patient care and clinical outcomes. The company recently expanded its portfolio with the acquisition of Nexus Medical, LLC, a pioneer in anti-reflux needleless connector technology. Nexus’ proprietary TKO® connector is designed to support safer, more consistent IV nutrition and medication delivery, particularly in NICU and PICU settings. This addition strengthens Avanos’ Specialty Nutrition Systems business and reinforces its commitment to safe, reliable therapy delivery for vulnerable patient populations. Together, Avanos and Nexus are advancing meaningful innovation to help clinicians deliver consistent, high-quality care.